fda warning peptides bpc-157 safety not approved Approval Status: Is It for Human Use? BPC-157 Just Cleared a Major

Being able to walk further, sleep on the affected side, or perform previously painful movements represents meaningful progress beyond simple pain relief

BPC-157 is dosed individually

Tesamorelin's Phase 3 trials and Sermorelin's original approval studies were built around HIV-associated lipodystrophy and pediatric growth failure, not muscle building, so their bodybuilding use rests on extrapolation rather than direct testing

Doses are not equivalent across routes, so published research treats each route's dosing separately

Body composition, liver, and safety Does tirzepatide preserve lean mass better than semaglutide

The Vasireddi review surveys the case-report literature on these uses